Jim Zheng

1.8k total citations
14 papers, 802 citations indexed

About

Jim Zheng is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jim Zheng has authored 14 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Virology, 4 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Jim Zheng's work include HIV Research and Treatment (5 papers), Hepatitis B Virus Studies (4 papers) and HIV/AIDS Research and Interventions (3 papers). Jim Zheng is often cited by papers focused on HIV Research and Treatment (5 papers), Hepatitis B Virus Studies (4 papers) and HIV/AIDS Research and Interventions (3 papers). Jim Zheng collaborates with scholars based in United States, Germany and India. Jim Zheng's co-authors include Daniel B. Tumas, Randall L. Halcomb, Grushenka H.I. Wolfgang, Abigail Fosdick, Christian Frey, Deborah Chavez, Robert E. Lanford, Luis D. Giavedoni, Kathleen M. Brasky and Bernadette Guerra and has published in prestigious journals such as Blood, Gastroenterology and The FASEB Journal.

In The Last Decade

Jim Zheng

14 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jim Zheng United States	10	507	379	230	188	152	14	802
Ana C. Tuyama United States	11	390 0.8×	233 0.6×	116 0.5×	100 0.5×	75 0.5×	13	622
Romina Salpini Italy	19	475 0.9×	427 1.1×	46 0.2×	409 2.2×	194 1.3×	62	902
Brenna C. Simons United States	17	404 0.8×	312 0.8×	290 1.3×	43 0.2×	115 0.8×	33	773
Giulia Morsica Italy	18	1.0k 2.0×	1.1k 2.9×	39 0.2×	241 1.3×	86 0.6×	73	1.3k
Carey Hwang United States	20	396 0.8×	250 0.7×	117 0.5×	802 4.3×	665 4.4×	49	1.2k
Angelina Villası́s-Keever United States	12	203 0.4×	98 0.3×	223 1.0×	199 1.1×	268 1.8×	24	701
Martin McMorrow Netherlands	7	357 0.7×	412 1.1×	57 0.2×	134 0.7×	149 1.0×	10	537
J O Nielsen Denmark	12	257 0.5×	201 0.5×	74 0.3×	135 0.7×	124 0.8×	23	484

Countries citing papers authored by Jim Zheng

Since Specialization

Citations

This map shows the geographic impact of Jim Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Zheng more than expected).

Fields of papers citing papers by Jim Zheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Zheng. The network helps show where Jim Zheng may publish in the future.

Co-authorship network of co-authors of Jim Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Zheng. A scholar is included among the top collaborators of Jim Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Zheng. Jim Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Zheng, Jim, Bing Lu, Gavin Carr, et al.. (2024). Lenacapavir Exhibits Atropisomerism—Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway. Journal of Pharmacology and Experimental Therapeutics. 391(1). 91–103. 6 indexed citations

Subramanian, Raju, Jennifer Tang, Jim Zheng, et al.. (2023). Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent. Molecular Pharmaceutics. 20(12). 6213–6225. 27 indexed citations

Tang, Jennifer, Hong Shen, Vinay K. Holenarsipur, et al.. (2021). Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition. Drug Metabolism and Disposition. 49(12). 1063–1069. 22 indexed citations

Zheng, Jim, Winston C. Tse, Bing Lu, et al.. (2021). Intestinal Excretion is a Major Disposition Pathway of Lenacapavir in Rat and Dog. The FASEB Journal. 35(S1). 1 indexed citations

Zheng, Jim, et al.. (2020). Characterization of Seasonal Pharmacokinetic Variability in Woodchucks. Drug Metabolism and Disposition. 48(11). 1199–1209. 1 indexed citations

Zheng, Jim, Xin Yan, Jingyu Zhang, et al.. (2018). Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development. Drug Metabolism and Disposition. 46(3). 237–247. 40 indexed citations

Zheng, Jim, Stephen R. Yant, Shekeba Ahmadyar, et al.. (2018). 539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans. Open Forum Infectious Diseases. 5(suppl_1). S199–S200. 12 indexed citations

Lavender, Kerry J., Craig S. Pace, Kathrin Sutter, et al.. (2017). An advanced BLT-humanized mouse model for extended HIV-1 cure studies. AIDS. 32(1). 1–10. 54 indexed citations

Warr, Matthew R., Malte Aßhoff, Jim Zheng, et al.. (2016). Preclinical Modeling of ACVR1-Dependent Hepcidin Production and Anemia By Momelotinib. Blood. 128(22). 1967–1967. 3 indexed citations

10.

Prete, Gregory Q. Del, Jeremy Smedley, Rhonda MacAllister, et al.. (2015). Short Communication: Comparative Evaluation of Coformulated Injectable Combination Antiretroviral Therapy Regimens in Simian Immunodeficiency Virus-Infected Rhesus Macaques. AIDS Research and Human Retroviruses. 32(2). 163–168. 65 indexed citations

11.

Menne, Stephan, Daniel B. Tumas, Dalal Aldeghaither, et al.. (2015). Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B. Journal of Hepatology. 62(6). 1237–1245. 167 indexed citations

12.

Lanford, Robert E., Bernadette Guerra, Deborah Chavez, et al.. (2013). GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees. Gastroenterology. 144(7). 1508–1517.e10. 298 indexed citations

13.

Fosdick, Abigail, Jim Zheng, Stefan Pflanz, et al.. (2013). Pharmacokinetic and Pharmacodynamic Properties of GS-9620, a Novel Toll-Like Receptor 7 Agonist, Demonstrate Interferon-Stimulated Gene Induction without Detectable Serum Interferon at Low Oral Doses. Journal of Pharmacology and Experimental Therapeutics. 348(1). 96–105. 55 indexed citations

14.

Roethle, Paul A., Ryan M. L. McFadden, Hon C. Hui, et al.. (2013). Identification and Optimization of Pteridinone Toll-like Receptor 7 (TLR7) Agonists for the Oral Treatment of Viral Hepatitis. Journal of Medicinal Chemistry. 56(18). 7324–7333. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana C. Tuyama Breakdown of academic impact, for papers by Romina Salpini Breakdown of academic impact, for papers by Brenna C. Simons Breakdown of academic impact, for papers by Giulia Morsica Breakdown of academic impact, for papers by Carey Hwang Breakdown of academic impact, for papers by Angelina Villası́s-Keever Breakdown of academic impact, for papers by Martin McMorrow Breakdown of academic impact, for papers by J O Nielsen